Table 2 Subjects studied in 46 randomized controlled trials reporting on QOL
Number of trials (%) | |||
|---|---|---|---|
Subjects | English Reports | Japanese Reports | Total |
Oncology | 15 (46.9) | 11 (78.6) | 26 (56.5) |
Cardiovascular diseases | 5 (15.6) | 0 (0.0) | 5 (10.9) |
Urology | 4 (12.5) | 2 (14.3) | 6 (13.0) |
Gastrointestinal diseases | 3 (9.4) | 1 (7.1) | 4 (8.7) |
Respiratory | 2 (6.3) | 0 (0.0) | 2 (4.3) |
Dentistry | 1 (3.1) | 0 (0.0) | 1 (2.2) |
Infection | 1 (3.1) | 0 (0.0) | 1 (2.2) |
Health* | 1 (3.1) | 0 (0.0) | 1 (2.2) |
Total | 32 (100.0) | 14 (100.0) | 46 (100.0) |